CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Vanda Pharmaceuticals stock falls after anxiety drug trial fails

Phase 2negativeNegative
AI Analysis

Summary

Vanda Pharmaceuticals' anxiety drug trial has failed, resulting in a decline in the company's stock price.

Clinical Trial Data

Primary Endpoint

Not Met

Outcome Details

anxiety drug trial failed

Importance:7/10
Sentiment:
-0.80
clinical_trial_failureanxietydrug_developmentstock_decline
Related Companies

Read the original article

Published by yahoo_finance on October 14, 2026 9:54 PM

Read Original